C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2001
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	WO2001040198A3 Macrocyclic hydroxamic acid derivatives and their use as antimicrobial agents
11/29/2001	WO2001034576A3 Use of pyrimidinone derivatives for controlling undesired microorganisms
11/29/2001	WO2001028996A3 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/29/2001	WO2000040210A3 Topical compositions comprising protected functional thiols
11/29/2001	US20010047105 EP4 receptor selective agonists in the treatment of osteoporosis
11/29/2001	US20010047038 Treating the patient suffering for herpes viruses, and cytomegalovirus with an effective amount of sulfur or sulfoxide or sulfonyl containing heteroaromatic compounds
11/29/2001	US20010047031 Heterocyclic compounds useful as NMDA receptor selective subtype blockers
11/29/2001	US20010047020 Benzimidazole derivatives, their production and use
11/29/2001	US20010046998 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
11/29/2001	US20010046985 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
11/29/2001	US20010046958 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
11/29/2001	EP1143916A3 Topical compositions comprising protected functional thiols
11/29/2001	DE10055499A1 6-Heterocyclyl-3-oxo-3,4-dihydro-chinoxaline 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
11/29/2001	DE10025949A1 Arzneimittel zur Bekämpfung von Atemdepression Medications to fight respiratory depression
11/29/2001	DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists
11/29/2001	CA2409998A1 Benzodiazepine derivatives as app modulators
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/28/2001	EP1157998A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors
11/28/2001	EP1157991A2 Herbicidal imidazolidinetrione and thioxo-imidazolidinediones
11/28/2001	EP1157726A1 Reactive crystallization method to improve particle size
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157019A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
11/28/2001	EP1157011A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
11/28/2001	EP1156803A1 LACTAM INHIBITORS OF FXa AND METHOD
11/28/2001	EP0784054B1 1,2,3,4-tetrahydroquinoxalinedione derivatives and use as glutamate receptor antagonists
11/28/2001	CN1324348A TAN-1057 derivatives
11/28/2001	CN1324250A Method for treating or preventing viral infections and associated diseases
11/27/2001	US6323228 3-substituted indole angiogenesis inhibitors
11/27/2001	US6323204 Analgesics, antiinflammatory agents and antiischemic agents
11/27/2001	US6323154 3-aryluracils and intermediates for their preparation
11/27/2001	CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/26/2001	CA2349136A1 Reactive crystallization method to improve particle size
11/22/2001	WO2001087887A2 Neuroprotective and anti-proliferative compounds
11/22/2001	WO2001087854A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087845A2 N-containing heterocyclic compounds and their use as 5-ht antagonists
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087834A1 Melanin-concentrating hormone antagonist
11/22/2001	WO2001087826A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/22/2001	WO2001087287A2 Use of pyrazole derivatives for treating infertility
11/22/2001	WO2001027080A3 5-substituted indolinones and use thereof as kinase and cyclin/cdk complex inhibitors
11/22/2001	US20010044535 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
11/22/2001	US20010044445 Azole inhibitors of cytokine production
11/22/2001	US20010044441 And female sexual dysfunction, premature labour or dysmenorrhea
11/22/2001	US20010044439 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as H3 antagonists
11/22/2001	US20010044433 Specific antitumor activity against breast, colon, lung, prostate cancers and melanomas
11/22/2001	CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001	CA2409445A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001	CA2408913A1 Melanin-concentrating hormone antagonist
11/22/2001	CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001	CA2405507A1 Use of pyrazole derivatives for treating infertility
11/22/2001	CA2375065A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/21/2001	EP1156047A1 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
11/21/2001	EP1156045A1 Amide derivatives and drug compositions
11/21/2001	EP1156043A2 Drugs that enhance synaptic responses mediated by ampa receptors
11/21/2001	EP1156039A1 Pyridazin-3-one derivatives and medicines containing the same
11/21/2001	EP1156037A1 Chondrongenesis promotors and indolin-2-one derivatives
11/21/2001	EP1155014A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
11/21/2001	EP1155012A1 Anti-cancer dihydroquinazoline derivatives
11/21/2001	EP1154997A1 Pharmaceutically active compounds and methods of use thereof
11/21/2001	EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001	EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
11/21/2001	EP0659179B1 Benzo-fused lactams promote release of growth hormone
11/21/2001	CN1323396A Endogenous constitutively activated G protein-coupled orphan receptors
11/21/2001	CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
11/21/2001	CN1323297A Pyridazinone derivatives
11/21/2001	CN1323295A AZA-bicycles which modulate the inhibition of cell adhesion
11/21/2001	CN1322725A Indole derivant
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/21/2001	CN1075070C Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use
11/21/2001	CN1074926C Antiarrhythmic benzodiazepines
11/20/2001	US6320047 Substituted aryl or heteroarylamides having retinoid-like biological activity
11/20/2001	US6319940 Carbanilides used as pesticides
11/20/2001	US6319939 Retinoic acid mimetic anlides
11/20/2001	US6319938 Prophylactic or therapeutic drug for renal diseases
11/20/2001	US6319922 Propanoic acid derivatives
11/20/2001	US6319921 Aromatic heterocyclic compound as antiinflammatory agents
11/20/2001	US6319917 Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
11/20/2001	CA2025599C Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
11/19/2001	CA2308994A1 Neuroprotective compounds
11/15/2001	WO2001085760A1 Thrombin inhibitors
11/15/2001	WO2001085729A1 Novel vitronectin receptor antagonists
11/15/2001	WO2001085724A1 Gastrin and cholecystokinin receptor ligands (iii)
11/15/2001	WO2001085723A1 Gastrin and cholecystokinin receptor ligands (ii)
11/15/2001	WO2001085720A1 Novel anti-infectives
11/15/2001	WO2001085718A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	WO2001085701A1 5-ht7 receptor antagonists
11/15/2001	WO2001085700A2 Hiv replication inhibiting pyrimidines and triazines
11/15/2001	WO2001085699A2 Prodrugs of hiv replication inhibiting pyrimidines

1 ... 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 ... 626